(Q46639089)

23 December 2017

title

Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine (English)

1 reference

23 December 2017

author name string

Stefan Schäfer

1

1 reference

23 December 2017

Jochen Huber

2

1 reference

23 December 2017

Cornelia Wihler

3

1 reference

23 December 2017

Hartmut Rütten

4

1 reference

23 December 2017

Andreas E Busch

5

1 reference

23 December 2017

Wolfgang Linz

6

1 reference

23 December 2017

publication date

8 August 2005

1 reference

23 December 2017

European Journal of Heart Failure

published in

1 reference

23 December 2017

volume

8

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

2-6

1 reference

23 December 2017

Diabetes and idiopathic cardiomyopathy: a nationwide case-control study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Advanced glycation endproducts--role in pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Evidence of incomplete left ventricular relaxation in the dog: prediction from the time constant for isovolumic pressure fall

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Elevated serum levels of N(epsilon)-carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Effects of a diet rich in advanced glycation end products in the rat remnant kidney model

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

RAGE axis: Animal models and novel insights into the vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.04.011

10.1016/J.EJHEART.2005.04.011

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

16085456

1 reference

23 December 2017